http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011253624-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d53094985a54e1cafd22f23d76be4007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2011-11-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ad30e6f40a9a055190a9dea9812e3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6713523b84f8f519a863fcee33d9d24 |
| publicationDate | 2011-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011253624-A1 |
| titleOfInvention | Method for the early detection of renal disease and injury |
| abstract | Method For The Early Detection Of Renal Disease And Injury Abstract The invention relates to a method and kit for detecting the early onset of renal disease and injury, including renal tubular injury, utilizing NGAL as an early blood serum biomarker. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the blood serum following renal tubule cell injury. NGAL protein expression is detected predominantly in proximal tubule cells, in a punctate cytoplasmic distribution reminiscent of a secreted protein. The appearance of NGAL in the serum is related to the dose and duration of renal ischemia and nephrotoxemia, and is diagnostic of renal tubule cell injury and renal failure. NGAL detection is also a useful marker for monitoring the nephrotoxic side effects of drugs or other therapeutic agents. |
| priorityDate | 2004-06-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 115 of 115.